๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The Japan Society of Gene Therapy (JSGT) joins forces with other Gene Therapy Societies

โœ Scribed by Shigetaka Asano

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
22 KB
Volume
4
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The 12th Annual Meeting 2006 Japan Socie
The 12th Annual Meeting 2006 Japan Society of Gene Therapy
๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 465 KB

Background: Cationic liposome-mediated interferon-beta (IFN-b) gene transfer has been found to induce regression of experimental glioma. We performed a pilot clinical trial to evaluate safety and effectiveness of this IFN-b gene therapy in five patients with malignant glioma (glioblastoma multiforme

The Journal of Gene Medicine Japan Socie
The Journal of Gene Medicine Japan Society of Gene Therapy Young Investigator Award 2004
โœ Ken Sakurai ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 36 KB

Sakurai was involved with two cases of lysosomal storage diseases (LSDs). One of the patients had GM1 gangliosidosis, and the other had neuronal ceroid lipofuscinosis. It was working on these enzyme deficiency cases that first triggered Dr Sakurai's interest in treatments for LSDs. Since finishing h

The 11th Annual Meeting of the Japan Soc
The 11th Annual Meeting of the Japan Society of Gene Therapy 2005
๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 449 KB

Severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) has been considered as one of the best candidate disease for clinical gene therapy. In deed, the first clinical gene therapy trial was performed in 1990-1991 for two patients with ADA-SCID using retrovirus vector (LASN